What Can We Learn from the Travelers Data in Detecting Disease Outbreaks -- A Case Study of the COVID-19 Epidemic
Le Bao, Ying Zhang, Xiaoyue Niu

TL;DR
This study demonstrates how traveler data can be effectively used to detect and monitor COVID-19 outbreaks, providing timely estimates of epidemic growth and informing policy decisions, with a new analytical framework and a user-friendly app.
Contribution
The paper introduces a method to estimate epidemic indicators from traveler data and compares it to domestic data, highlighting its potential for early outbreak detection.
Findings
Traveler data estimates aligned with domestic data when assumptions held.
Critical outbreak detection dates matched policy decision dates.
Recent traveler cases had a larger impact on estimates.
Abstract
Background: Travel is a potent force in the emergence of disease. We discussed how the traveler case reports could aid in a timely detection of a disease outbreak. Methods: Using the traveler data, we estimated a few indicators of the epidemic that affected decision making and policy, including the exponential growth rate, the doubling time, and the probability of severe cases exceeding the hospital capacity, in the initial phase of the COVID-19 epidemic in multiple countries. We imputed the arrival dates when they were missing. We compared the estimates from the traveler data to the ones from domestic data. We quantitatively evaluated the influence of each case report and knowing the arrival date on the estimation. Findings: We estimated the travel origin's daily exponential growth rate and examined the date from which the growth rate was consistently above 0.1 (equivalent to doubling…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 epidemiological studies · Data-Driven Disease Surveillance · COVID-19 Pandemic Impacts
